(Stroke. 1999;30:66-69.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology (M.G., M.B., R.K., T.B., S.J., C-W.W.) and the Institute of Clinical Chemistry (G.L.), University of Magdeburg, Magdeburg, Germany.
Correspondence to Dr M. Goertler, Department of Neurology, University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany. E-mail michael.goertler{at}medizin.uni-magdeburg.de
Background and PurposeThe present study investigated the influence of the antiplatelet agent acetylsalicylic acid (ASA) on cerebral microembolism as detected by transcranial Doppler sonography (TCD).
MethodsNine patients with recent transient ischemic attack or minor stroke of arterial origin were investigated. Eight had not received an antiplatelet or anticoagulant medication before TCD, and in 1 patient a preexisting ASA medication (100 mg/d) had not been changed since the onset of stroke symptoms. An initial 1-hour TCD monitoring was extended for an additional 2.5 hours after an intravenous bolus injection of 500 mg ASA and was repeated for 1 hour on the following day.
ResultsMicroembolic signals (MES) were detected in all patients only on the symptomatic side. After the ASA bolus injection, a significant drop of the MES rate was found in 7 patients, all without previous medication, starting 30 minutes after the application (mean per hour=25.1 [range, 6 to 66] versus mean per hour=6.4 [range, 0 to 14]). In 3 of these patients, platelet aggregation tests were performed that demonstrated normal aggregation before bolus injection and inhibited aggregability as early as 30 minutes after bolus injection. The rate of MES remained unchanged in 1 patient without antiplatelet medication. The ninth patient, who had suffered an ischemic event on ASA, showed only a transient decrease of MES frequency.
ConclusionsIn patients with recent stroke of arterial origin, intravenous ASA can rapidly reduce cerebral microemboli as detected by TCD. Microemboli might be a useful parameter to monitor early effects of antiplatelet therapy.
Key Words: antiplatelet agents carotid artery stenosis cerebral embolism stroke ultrasonography, Doppler
This article has been cited by other articles:
![]() |
A. King and H. S. Markus Doppler Embolic Signals in Cerebrovascular Disease and Prediction of Stroke Risk: A Systematic Review and Meta-Analysis * Supplemental Online References Stroke, December 1, 2009; 40(12): 3711 - 3717. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Ringelstein and R. Dittrich MES, what a mess! A modern version of Russian roulette J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 238 - 238. [Full Text] [PDF] |
||||
![]() |
H. Poppert, S. Sadikovic, K. Sander, O. Wolf, and D. Sander Embolic Signals in Unselected Stroke Patients: Prevalence and Diagnostic Benefit Stroke, August 1, 2006; 37(8): 2039 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sztajzel, I. Momjian-Mayor, M. Comelli, and S. Momjian Correlation of Cerebrovascular Symptoms and Microembolic Signals With the Stratified Gray-Scale Median Analysis and Color Mapping of the Carotid Plaque Stroke, March 1, 2006; 37(3): 824 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
P H Lee, S H Oh, O Y Bang, I S Joo, and K Huh Pathogenesis of deep white matter medullary infarcts: a diffusion weighted magnetic resonance imaging study J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1659 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Markus, D. W. Droste, M. Kaps, V. Larrue, K. R. Lees, M. Siebler, and E. B. Ringelstein Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial Circulation, May 3, 2005; 111(17): 2233 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Blaser, W. Glanz, S. Krueger, C.-W. Wallesch, S. Kropf, and M. Goertler Time Period Required for Transcranial Doppler Monitoring of Embolic Signals to Predict Recurrent Risk of Embolic Transient Ischemic Attack and Stroke From Arterial Stenosis Stroke, September 1, 2004; 35(9): 2155 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Higashida, P. M. Meyers, C. C. Phatouros, J. J. Connors III, J. D. Barr, D. Sacks, and for the Technology Assessment Committees of the Am Reporting Standards for Carotid Artery Angioplasty and Stent Placement Stroke, May 1, 2004; 35(5): e112 - e134. [Full Text] [PDF] |
||||
![]() |
P. H. Lee, S. -H. Oh, O. Y. Bang, S. -Y. Joo, I. S. Joo, and K. Huh Infarct patterns in atherosclerotic middle cerebral artery versus internal carotid artery disease Neurology, April 27, 2004; 62(8): 1291 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Ferguson If There's Smoke, Is There Fire? Circulation, March 30, 2004; 109(12): 1442 - 1444. [Full Text] [PDF] |
||||
![]() |
P. H. Lee, O. Y. Bang, S. H. Oh, I. S. Joo, and K. Huh Subcortical White Matter Infarcts: Comparison of Superficial Perforating Artery and Internal Border-Zone Infarcts Using Diffusion-Weighted Magnetic Resonance Imaging Stroke, November 1, 2003; 34(11): 2630 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Nabavi, J. Stockmann, C. Schmid, M. Schneider, D. Hammel, H. H. Scheld, and E. B. Ringelstein Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 160 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Junghans and M. Siebler Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist Circulation, June 3, 2003; 107(21): 2717 - 2721. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Russell and R. Brucher Online Automatic Discrimination Between Solid and Gaseous Cerebral Microemboli With the First Multifrequency Transcranial Doppler Stroke, August 1, 2002; 33(8): 1975 - 1980. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Goertler, T Blaser, S Krueger, K Hofmann, M Baeumer, and C-W Wallesch Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 338 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Phatouros, R. T. Higashida, A. M. Malek, P. M. Meyers, T. E. Lempert, C. F. Dowd, and V. V. Halbach Carotid Artery Stent Placement for Atherosclerotic Disease: Rationale, Technique, and Current Status Radiology, October 1, 2000; 217(1): 26 - 41. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |